This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nature Reviews Cardiology, Published online: 10 April 2024; doi:10.1038/s41569-024-01017-x Patients with cardiovascular disease (CVD) have an increased risk of cancer, and patients with cancer have an increased risk of CVD.
The findings – published this week in the Journal of the American College of Cardiology — could fuel advocacy for a paradigm shift in clinical heart health guidelines to address cardiovascular riskfactors at an earlier age in childhood cancer survivors. “We Wendy Bottinor, MD.
Nearly 80% of patients with lung cancer had detectable atherosclerosis on their cancer staging CT scans and other cardiovascular riskfactors were common, offering an opportunity for earlier cardiac testing and riskfactor modification, according to a new study.
Getty Images milla1cf Wed, 06/19/2024 - 20:54 June 19, 2024 — Modern therapies have extended the lives of many cancer patients; however, survivors often live with chronic health conditions, including cardiovascular disease. They found that exposure to PM2.5,
Background Cancer survivors are at increased risk of heart failure (HF). While cardiotoxicity is commonly sought at the time of cancer chemotherapy, HF develops as a result of multiple ‘hits’ over time, and there is limited evidence regarding the frequency and causes of HF during survivorship. compared with 1.7%
Insulin resistance is a major riskfactor for the leading causes of death, the leading one being cardiovascular disease. Understanding where you sit on this continuum is a key part of defining your future risk of heart disease but also dementia, and many cancers. The key is to identify risk much earlier.
The riskfactors for postoperative embolism included Black race, interstitial fibrosis, advanced-stage disease requiring bilobectomy or pneumonectomy, and increased operative duration. occurrence of postoperative PE in patients undergoing a first-time pulmonary resection for lung cancer. occurrence of postoperative VTE and a 1.3%
Air pollution can greatly increase the risk of cardiovascular disease and mortality in patients with cancer and can contribute to health disparities related to both conditions,
Sleep apnea is prevalent among patients at higher risk for developing congestive heart failure (CHF) following cancer treatment and could be used as a riskfactor to identify patients who would benefit from earlier treatment, according to a study being presented at ACC’s Advancing the Cardiovascular Care of the Oncology Patient course.
New research shows that many cases of cancer and resulting deaths could have been prevented if Americans modified some of their unhealthy lifestyle habits.
Lung cancer screening with low-dose chest computed tomography (CT) may detect more than just lung cancer. As research in the Canadian Medical Association Journal shows, these CTs can identify coronary artery calcium, a strong riskfactor for coronary artery disease (CAD), in patients without cardiac symptoms.
Several cardiovascular riskfactors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, according to a new study being presented at ACC's Advancing the Cardiovascular Care of the Oncology Patient course.
Active cancer is a strong riskfactor for venous thromboembolism (VTE) events and recurrent events following discontinuation of anticoagulation therapy, and cancer patients are also at a heightened risk for bleeding complications related to anticoagulation treatment.
Investigators examined data from the Global Burden of Disease, Injuries, and RiskFactors study 2019 to describe the global, regional, and national burden of liver cancer due to hepatitis C since 1990.
Cancer and cardiovascular disease represent the two leading causes of morbidity and mortality worldwide. These traditional cardiovascular riskfactors not only increase their lifetime risk of heart failure but also their overall risk of cancer. Women continue to enjoy a greater life expectancy than men.
As patient factors are added by the user, the risk estimates of morbidity and mortality are dynamically calculated along with 95% confidence intervals. Key updates include the incorporation of new riskfactors such as preoperative cancer staging and body surface area. Contact the STS Research and Analytic Center.
A growing body of research has identified circadian-rhythm disruption as a riskfactor for metabolic health. Findings have important implications for the treatment, prevention, and control of metabolic pathologies underlying leading causes of death and disability, including diabetes, cardiovascular disease, and cancer.
This study sought to evaluate the prevalence of cardiovascular riskfactors, overt cardiovascular disease and cardiac imaging abnormalities using cardiac magnetic resonance (CMR), in participants with normal LVEF on completion of trastuzumab±anthracycline therapy at least 5 years previously.
BackgroundThere existed bidirectional associations of cardiovascular disease (CVD) and type 2 diabetes (T2D) with cancer, partly attributed to their shared riskfactors. This highlighted the significance of maintaining high CVH throughout the life span for the primary prevention of CVD, T2D, and cancer.
It’s not that they don’t get cardiovascular disease, cancer or dementia; they just get it way later than everyone else. When broken down by disease category, cardiovascular disease, cancer, dementia, stroke, osteoarthritis, hypertension and stroke, the pattern is the same. Aggressively control the riskfactors.
Lung cancer is the second most common form of cancer in the United States, with approximately 125,000 lives estimated to be lost this year. Because its symptoms are commonly associated with so many other conditions, like a cough and chest pain, lung cancer can be hard to diagnose.
Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascular riskfactors in patients with hemophilia compared to the general population.
Better treatments have led to improved cancer survival rates, but new research reveals increased cardiovascular complications in survivors. However, another new study offers hope, suggesting that heart medications like SGLT2 inhibitors may help prevent cancer-related heart disease. smoking) and cancer-induced riskfactors (e.g.
Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share riskfactors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both conditions. Whether the risks of outcomes differ according to temporal order of AF and AMI is unclear.
It usually takes many years of being exposed to an uncontrolled riskfactor such as high blood pressure, high LDL cholesterol or diabetes. Even if they have controlled all of their known riskfactors. However, it just happens way less often to those who have controlled their riskfactors. Manage Risk.
Children who suffer arterial ischemic stroke (AIS) while hospitalized are often critically ill and may have distinct acute and chronic riskfactors, stroke characteristics and outcomes compared to those with outpatient strokes. Stroke, Volume 56, Issue Suppl_1 , Page ATMP95-ATMP95, February 1, 2025.
The number of patients at the intersection of cancer and cardiovascular disease (CVD) is increasing, reflecting ageing global populations, rising burden of shared cardiometabolic riskfactors, and improved cancer survival. Many cancer treatments carry a risk of cardiotoxicity.
Background:Cancer is a leading cause of mortality and a well-known riskfactor for ischemic stroke. However, the relationship between cancer and stroke is not well studied. This result is consistent with a recent study in this area indicating a higher rate of shunt among patients without cancer than those with cancer.
Cardiovascular disease, cancer and dementia account for 60% of all deaths in the US. Yes, many external factors impact these factors, but ultimately, you have significant control over all of these. Let’s look at what happens to NCD risk when these riskfactors are optimised. These are NCD’s.
More than heart disease or cancer, the risk of dementia often creates much greater anxiety in the patients I see. Recent data suggests that 14 modifiable factors account for 45% of the future risk of dementia. Not all of these factors are created equal, and when you address these riskfactors is also relevant.
Background Cancer therapy-related cardiac dysfunction due to trastuzumab has been well-known for many years, and echocardiographic surveillance is recommended every 3 months in patients undergoing trastuzumab treatment, irrespective of the baseline cardiotoxicity risk.
It kills almost twice as many people globally when compared to all cancers combined. The real question is what the Tsimane tribe's riskfactor profile looks like. As a consequence, high blood pressure is the single most important riskfactor for early death worldwide 8. Minimising cardiovascular risk is possible.
Riskfactors for late autograft dysfunction include a dilated aortic annulus and ascending aorta. Freedom from pulmonary regurgitation was lower97% at 5 years, 83.6% at 10 years, 79.7% at 15 years, and 75.1% at 20 years. Individuals aged 18 years or younger exhibit notably higher rates of aortic regurgitation, Dr. Shetty observed.
When stress is included in the riskfactor profile for a future heart attack, it comes in third on the list after abnormal cholesterol and smoking 1. But it’s not just natural disasters and war that have been linked to a higher risk of events. Bring back the real emergencies, I say! The link is real. JAMA Netw Open.
They are dying less often from the two leading causes of death: Cardiovascular Disease and Cancer. For each factor achieved, the risk of dying from either of these two conditions drops significantly. JAMA Cardiol 2021;6:437–47 2 10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus.
Objective Adjuvant chemotherapy with trastuzumab improves the postoperative life expectancy of women with early-stage breast cancer. Women with breast cancer who underwent initial surgery were included. Although trastuzumab is reportedly cardiotoxic, quantification based on real-world evidence is lacking.
Diabetes is a well‐known riskfactor for ischemic heart disease. BackgroundPostpancreatectomy diabetes can be caused by resection of functioning pancreatic tissue and is associated with postoperative pancreatic islet cell mass loss and subsequent endocrine dysfunction.
Therefore, we aimed to assess a possible interaction between lifestyle and genetics on AF risk. Methods We included AF cases and a randomly drawn subcohort of 4040 participants from the Danish Diet, Cancer and Health cohort. Conclusions The rates of AF increased gradually with worse lifestyle within each category of genetic risk.
Objective This study aimed to assess the incidence of early cancer therapy-related cardiac dysfunction (CTRCD) and the characteristics of left and right heart deformations during anthracycline chemotherapy.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content